Table 2. Initial characteristics of the... | American Society of Hematology

Table 2.

Initial characteristics of the 386 adult patients with early/intermediate Hodgkin disease included in the H90-NM trial

	All	Arm E (EBVMm-RT)	Arm A (ABVDm-RT)
Patients	386	186	200
Sex
Male	206	90	116
Female	180	96	84
Age
Younger than 40 years	279	132	147
40 years and older	107	54	53
Histology
Nodular sclerosis	260	132	128
Other subtypes	126	54	72
Clinical stages
IA	81	33	48
IIA	195	95	100
IIIA	25	12	13
IB-IIB	65	36	29
IIIB	20	10	10
Clinical presentation
Supradiaphragmatic CS I/II:
With MMR less than 0.33:
No symptoms	211	96	115
Symptoms	46	26	20
MMR 0.33 and greater and less than 0.45	64	34	30
Infradiaphragmatic CS I/II	20	8	12
CS III	45	22	23
Contiguous extra nodal involvement
No	371	179	192
Yes	15	7	8

	All	Arm E (EBVMm-RT)	Arm A (ABVDm-RT)
Patients	386	186	200
Sex
Male	206	90	116
Female	180	96	84
Age
Younger than 40 years	279	132	147
40 years and older	107	54	53
Histology
Nodular sclerosis	260	132	128
Other subtypes	126	54	72
Clinical stages
IA	81	33	48
IIA	195	95	100
IIIA	25	12	13
IB-IIB	65	36	29
IIIB	20	10	10
Clinical presentation
Supradiaphragmatic CS I/II:
With MMR less than 0.33:
No symptoms	211	96	115
Symptoms	46	26	20
MMR 0.33 and greater and less than 0.45	64	34	30
Infradiaphragmatic CS I/II	20	8	12
CS III	45	22	23
Contiguous extra nodal involvement
No	371	179	192
Yes	15	7	8

MMR indicates mediastinal mass ratio (defined in “Patients and methods”).